“Pharma continues turning to AI to better understand diseases and speed up drug discovery and development,” said Noam Solomon ...

Pfizer CEO Albert Bourla said on Monday the drugmaker might move overseas manufacturing to its existing plants in the United ...

Discover the strengths & weaknesses of healthcare giants Johnson & Johnson and Pfizer. Find out which stock is more promising ...

As biopharma players continue to parse out what the second Trump administration means for the industry, Pfizer CEO Albert ...

U.S. President Donald Trump has issued a memorandum directing federal agencies to restrict inbound and outbound investments ...

Investing in dividend stocks can be a great strategy, especially if you pick solid companies that pay reliable and high-yield ...

Pfizer's Q4/24 results showed significant improvements, with total revenue up 21.9% YoY and adjusted diluted EPS increasing ...

Bangladesh’s pharmaceutical exports posted steady growth in the first eight months of the current fiscal year, buoyed by ...

In this Pharmaceutical Executive Video Interview, Peter Ax, Founder & CEO of UpScriptHealth, describes how his company's ...

Pfizer CEO Albert Bourla on Monday said that the company might move overseas manufacturing to its existing plants in the ...

Eli Lilly also responded to the President's tariff warnings by investing $27 billion to construct four manufacturing ...

"I was expecting him probably to win. It was very big win," Pfizer's CEO Albert Bourla said of President Donald Trump's ...